Research Report for: Heat Biologics, Inc. (NASDAQ:HTBX)


Heat Biologics, Inc. (NASDAQ:HTBX) reported the earnings of $-0.08/Share in the last quarter where the estimated EPS by analysts was $-0.15/share. The difference between the expected and actual EPS was $0.07/share, which represents an Earnings surprise of 46.7%.

Many analysts are providing their Estimated Earnings analysis for Heat Biologics, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.1/share. These analysts have also projected a Low Estimate of $-0.12/share and a High Estimate of $-0.07/share.

Some buy side analysts are also providing their Analysis on Heat Biologics, Inc., where 0 analysts have rated the stock as Strong buy, 2 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 2 Analysts reported that the Price Target for Heat Biologics, Inc. might touch $7 high while the Average Price Target and Low price Target is $4.88 and $2.75 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Heat Biologics, Inc. got Initiated on 20-Jun-16 where investment firm ROTH Capital Initiated the stock to Buy.

Heat Biologics, Inc. closed its last trading session at $3.23 with the loss of -7.74%. The Market Capitalization of the company stands at 71.13 Million. The Company has 52-week high of $4.71 and 52-week low of $0.4. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 90.6% where SMA50 and SMA200 are 110.54% and 185.37% respectively. The Company Touched its 52-Week High on Jan 6, 2016 and 52-Week Low on May 13, 2016.

The Relative Volume of the company is 6.04 and Average Volume (3 months) is 1.38 million. Heat Biologics, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -140.5%. The Return on Equity (ROE) value stands at -316%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Heat Biologics, Inc. currently shows a Weekly Performance of 105.52%, where Monthly Performance is 111.35%, Quarterly performance is 97.35%, 6 Months performance is 344.78% and yearly performance percentage is -3.87%. Year to Date performance value (YTD perf) value is 22.13%. The Stock currently has a Weekly Volatility of 26.38% and Monthly Volatility of 13.90%.